CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in BIOA — BioAge Labs, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,324,857
+$1,416,348 QoQ
Shares Held
247,276
+12.5% QoQ
Ownership
0.556%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. BIOA ranks #30 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,717,247 | $439,415,767 | |
| 2 | VTRS |
Viatris Inc
|
13,674,306 | $184,739,874 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
300,481 | $178,179,223 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
902,788 | $118,933,291 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,577,850 | $85,617,950 | |
| 6 | ALKS |
Alkermes plc.
|
2,236,756 | $79,091,692 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,087,679 | $62,880,891 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
657,413 | $49,864,776 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,324,857 | 247,276 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,908,509 | 219,842 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,125,332 | 191,383 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $496,888 | 120,312 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $338,313 | 89,977 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $491,379 | 84,867 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||